NASDAQ:AKU opened at $0.90 on Friday. The stock’s 50 day moving average price is $1.04 and its 200 day moving average price is $1.41. The company has a market capitalization of $80.14 million, a PE ratio of -1.92 and a beta of 0.07. Akumin has a 52-week low of $0.89 and a 52-week high of $3.58.
AKU has been the topic of several analyst reports. National Bankshares downgraded Akumin from a “sector perform” rating to an “underperform” rating and lowered their target price for the company from $2.00 to $0.75 in a research note on Wednesday, February 2nd. National Bank Financial downgraded Akumin from a “sector perform” rating to an “underperform” rating and lowered their target price for the company from $2.00 to $0.75 in a research note on Wednesday, February 2nd.
About Akumin (Get Rating)
Akumin Inc provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and other diagnostic or interventional radiology procedures through a network of approximately 200 owned and/or operated imaging locations.
- Get a free copy of the StockNews.com research report on Akumin (AKU)
- AMD (NASDAQ: AMD) Shines Green In A Sea Of Red
- Expedia or Bookings Holdings: Which Stock Should You Travel With?
- Is This The Bottom For Papa John’s International?
- Kellogg Company Flexes Pricing Power, Shares Move Higher
- Peak Growth Is Over For Etsy
Receive News & Ratings for Akumin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akumin and related companies with MarketBeat.com's FREE daily email newsletter.